BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33883194)

  • 21. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM; Backlund JY; Bayless M; Bluemke DA; Cleary PA; Crandall J; Lachin JM; Lima JA; Miao C; Turkbey EB;
    Diabetes; 2013 Oct; 62(10):3561-9. PubMed ID: 23520132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
    Hainsworth DP; Bebu I; Aiello LP; Sivitz W; Gubitosi-Klug R; Malone J; White NH; Danis R; Wallia A; Gao X; Barkmeier AJ; Das A; Patel S; Gardner TW; Lachin JM;
    Diabetes Care; 2019 May; 42(5):875-882. PubMed ID: 30833368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of Electrocardiographic Abnormalities in Type 1 Diabetes During 16 Years of Follow-up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Soliman EZ; Backlund JY; Bebu I; Li Y; Zhang ZM; Cleary PA; Lachin JM;
    J Am Heart Assoc; 2016 Mar; 5(3):e002882. PubMed ID: 26976878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study.
    Fahrmann ER; Adkins L; Driscoll HK
    Diabetes Care; 2021 Sep; 44(9):2132-2139. PubMed ID: 34233927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hearing Impairment and Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    Schade DS; Lorenzi GM; Braffett BH; Gao X; Bainbridge KE; Barnie A; Cruickshanks KJ; Dalton D; Diminick L; Gubitosi-Klug R; Kramer JR; Lachin JM; Larkin ME; Cowie CC;
    Diabetes Care; 2018 Dec; 41(12):2495-2501. PubMed ID: 30254082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Writing Group for the DCCT/EDIC Research Group
    Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT/EDIC study.
    Helmink MAG; Hageman SHJ; Visseren FLJ; de Ranitz-Greven WL; de Valk HW; van Sloten TT; Westerink J
    Diabet Med; 2023 Nov; 40(11):e15183. PubMed ID: 37470718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data.
    Lagani V; Chiarugi F; Thomson S; Fursse J; Lakasing E; Jones RW; Tsamardinos I
    J Diabetes Complications; 2015; 29(4):479-87. PubMed ID: 25772254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.
    Basu A; Bebu I; Jenkins AJ; Stoner JA; Zhang Y; Klein RL; Lopes-Virella MF; Garvey WT; Budoff MJ; Alaupovic P; Lyons TJ;
    J Lipid Res; 2019 Aug; 60(8):1432-1439. PubMed ID: 31203233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Lenherr SM; Clemens JQ; Braffett BH; Dunn RL; Cleary PA; Kim C; Herman WH; Hotaling JM; Jacobson AM; Brown JS; Wessells H; Sarma AV;
    Diabet Med; 2016 Nov; 33(11):1528-1535. PubMed ID: 27028025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM; Orchard TJ; Nathan DM;
    Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
    Polak JF; Backlund JC; Budoff M; Raskin P; Bebu I; Lachin JM;
    J Am Heart Assoc; 2021 Dec; 10(24):e022922. PubMed ID: 34873921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Observational Study of the Equivalence of Age and Duration of Diabetes to Glycemic Control Relative to the Risk of Complications in the Combined Cohorts of the DCCT/EDIC Study.
    Bebu I; Braffett BH; Schade D; Sivitz W; Malone JI; Pop-Busui R; Lorenzi GM; Lee P; Trapani VR; Wallia A; Herman WH; Lachin JM;
    Diabetes Care; 2020 Oct; 43(10):2478-2484. PubMed ID: 32788280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.